TABLE 5.
Change in medicine use from hospital admission to discharge
Characteristics | AOR (95% CI) a , P‐value | |
---|---|---|
With dementia | Without dementia | |
Hyperpolypharmacy | 1.95 (0.90–4.23), .09 | 2.38 (1.14–4.98), .02 |
Psychotropic medicines useb | 1.52 (0.72–3.19), .27 | 0.93 (0.43–2.01), .85 |
PIM use defined by beers Criteriac | 1.57 (0.67–3.69), .29 | 1.58 (0.61–4.14), .34 |
PIM use defined by STOPP Criteriac | 1.09 (0.48–2.44), .87 | 0.75 (0.26–2.18), .60 |
Fall‐related STOPP criteria PIM usec | 1.28 (0.57–2.86), .55 | 0.61 (0.20–1.93), .40 |
Fall‐related beers criteria PIM usec | 1.44 (0.67–3.10), .34 | 1.43 (0.62–3.32), .40 |
AOR shown for time‐periods (hospital discharge vs admission), adjusted for age, sex, length of hospital stay, age‐adjusted Charlson Comorbidity Index; b excluding antidementia medicines; c modelling the probability that patient is exposed to at least 1 PIM.